IP Verse

Sun Pharmaceutical Industries, Ltd. et al. vs Novartis Pharmaceuticals Corporation

The detailed information for PTAB case with proceeding number IPR2017-01929 filed by Sun Pharmaceutical Industries, Ltd. et al. against Novartis Pharmaceuticals Corporation on Aug 16, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2017-01929
Filing Date: Aug 16, 2017
Petitioner: Sun Pharmaceutical Industries, Ltd. et al.
Respondent: Novartis Pharmaceuticals Corporation
Status: Terminated
Respondent Application Number: 14257342
Respondent Tech Center: 1600
Respondent Patent Number: 9187405
Institution Decision Date: Oct 2, 2017
Termination Date: Aug 7, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
IPR2017-00854 Final Written Decision (IPR2017-01929 joined with this proceeding)	Aug 7, 2018	PAPER	BOARD
Order - Conduct of the Proceeding - Discovery under 37 CFR 41.51(b)(1); Ordering Briefing on Discovery under 37 CFR 41.52(b)(2)	Jan 11, 2018	PAPER	BOARD
Trial Instituted Document	Oct 2, 2017	PAPER	BOARD
Exhibit 3001	Oct 2, 2017	EXHIBIT	BOARD
PO Mandatory Notice	Sep 5, 2017	PAPER	PATENT OWNER
PO Power of Attorney	Sep 5, 2017	PAPER	PATENT OWNER
Notice of Accord Filing Date	Aug 25, 2017	PAPER	BOARD
Ex. 1001 - U.S. Patent No. 9,187,405	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1003 - Curriculum Vitae of Dr. Barbara S. Giesser	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1004 - John Kovarik and Silke Appel-Dingemanse: International Publication No. WO 2006/058316	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1005 - Thomson, FTY720 in Multiple Sclerosis: (2006)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1006 - U. S. Patent No. 6,004,565 (Chiba)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1007 - Kappos, L., et al., FTY720 in Relapsing MS: Results of a Double-Blind Placebo-Controlled Trial with a Novel Oral Immunomodulator, (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1008 - Budde, et al., First Human Trial of FTY720, a Novel Immunomodulatory, in Stable Renal Transplant Patients (2002)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1009 - File History U.S. Patent Application No. 12/303,765	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1010 - File History U.S. Patent Application No. 13/149,468 - Part 1	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1010 - File History U.S. Patent Application No. 13/149,468 - Part 2	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1011 - File History U.S. Patent Application No. 14/257,342	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1012 - GB 0612721.1	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1013 - U.S. Pat. No. 8,741,963	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1014 - File History of U.S. Patent Application No. 11/720,205 - Part 1	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1014 - File History of U.S. Patent Application No. 11/720,205 - Part 2	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1014 - File History of U.S. Patent Application No. 11/720,205 - Part 3	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1015 - Provisional Patent Application No. 60/631,483 (filed November 29, 2004)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1016 - Virley, Developing Therapeutics for the Treatment of Multiple Sclerosis (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1017 - Adachi, et al., Design, Synthesis, and Structure-Activity Relationships of 2-Substituted-2-amino-1,3-propanediols(1995)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1018 - Dumont, Fingolimod Mitsubishi Pharma/Novartis (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1019 - Park, et al., Pharmacokinetic Pharmacodynamic Relationships of FTY720 in Kidney Transplant Recipients, (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1020 - Yanagawa, et al., FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats, (1998)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1021 - "Clinical Pharmacology in the Critically Ill Child," in CRITICAL CARE PEDIATRICS, Zimmerman and Gildea eds. (Saunders Company 1985)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1022 - Chiba, FTY720, a New Class of Immunomodulatory, Inhibits Lymphocyte Egress from Secondary Lymphoid Tissues (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1023 - MCALPINE'S MULTIPLE SCLEROSIS, 4th Edition, Compston, ed (Elsevier, Inc., December 2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1024 - Frohman, et al., Multiple Sclerosis - The Plaque and its Pathogenesis (2006)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1025 - Inglese, Multiple Sclerosis: New Insights and Trends (2006)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1026 - Dragun, D., et al., FTY720: Early Clinical Experience, (2004)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1027 - Kahan, B.D., FTY720: A New Dimension in Transplantation (2001)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1028 - Fujino, et al., Amelioration of Experimental Autoimmune Encephalomyelitis in Lewis Rats by FTY720 Treatment (2003)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1029 - Kataoka, et al., FTY720, Sphingosine 1-Phosphate Receptor Modulator, Ameliorates Experimental Autoimmune Encephalomyelitis (2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1030 - Kahan, B.D., Sirolimus and FTY720: New Approaches to Transplant Immunosuppression (2002)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1031 - Kahan, et al., Pharmacodynamics, Pharmacokinetics, and Safety of Multiple Doses of FTY720 in Stable Renal Transplant Patients (2003)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1032 - Final Written Decision, Paper 112, IPR2014-00784	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1033 - PHYSICIANS' DESK REFERENCE, 59th Edition (Thomson PDR, January 1, 2005)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1034 - "Introduction to Pharmacokinetics" in BIOPHARMACEUTICS AND CLINICAL PHARMACOKINETICS, Gibaldi (Lea & Febiger, 1991)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1035 - Orange Book entry for Fingolimod (last accessed February 2, 2017)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1036 - FDA approval letter for Tysabri, obtained from the Food and Drug Administration (last accessed January 30, 2017)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1037 - U. S. Pat. No. 8,324,283 (Oomura)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1038 - Kappos, L., et al., A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis (2010)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1039 - LaMontagne, et al., "Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis," (Jan. 2006)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1040 - Thomson, FTY720 in Multiple Sclerosis (2006)	Aug 16, 2017	EXHIBIT	PETITIONER
Petitioner's Power of Attorney	Aug 16, 2017	PAPER	PETITIONER
Ex. 1041 - Federal Circuit decision in Novartis AG v. Torrent Pharms. Ltd., No. 2016-1352 (Apr. 12, 2017)	Aug 16, 2017	EXHIBIT	PETITIONER
Ex. 1002 - Declaration of Dr. Barbara S. Giesser	Aug 16, 2017	EXHIBIT	PETITIONER
PETITION FOR INTER PARTES REVIEW '405	Aug 16, 2017	PAPER	PETITIONER
MOTION FOR JOINDER UNDER 35 U.S.C.	Aug 16, 2017	PAPER	PETITIONER